Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenu

Axonics, Inc. , a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported preliminary unaudited...

Related Keywords

Boston , Massachusetts , United States , Raymondw Cohen , , Axonics Inc , Axonic Investor Relations Department , Boston Scientific Corporation , Exchange Commission , Nasdaq , Party Transactions , Axonic Investor Relations , Axonic Definitive Proxy Statement , Certain Beneficial Owners , Executive Officers , Axonic Current Report , Definitive Proxy Statement , Initial Statement , Beneficial Ownership , Annual Statement , Securities Litigation Reform Act , Axonic Annual Report , Axonic Quarterly Report , Markets ,